Clin2
NCT01894308Possibly a fitNot yet recruiting

Testosterone gel for men with low testosterone

Hypogonadotropism

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests a new testosterone gel at different doses to see how it affects men with low testosterone (below 300 ng/dL). It aims to find the right dose that safely and effectively raises testosterone levels in men aged 18-75.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
48 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are a man aged 18 to 75 with low testosterone (below 300 ng/dL).
  • Your weight must be in a healthy range for your height (BMI 18-30).
  • You are a non-smoker and in generally good health.
  • You agree to have a small tube placed in your arm twice to collect blood samples.
  • You are willing to follow the test schedule and visit the study site as required.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02733133Not yet recruiting· Phase 2
Testosterone patch transfer study in couples

This study tests whether testosterone from a skin patch can transfer from one person to another during close contact. It helps understand if wearing the patch could affect a partner.

NCT07328542Not yet recruiting· Phase 4
Testosterone therapy and blood pressure monitoring in men

This study looks at how testosterone therapy affects blood pressure over 24 hours in men with low testosterone. It may help you understand how this treatment could affect your heart health.

Birmingham, Alabama
NCT07278362Not yet recruiting· Phase 4
Testosterone therapy for low testosterone with low-risk prostate cancer

This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are under active surveillance. It aims to see if treatment can help without worsening the cancer.

Miami, Florida
NCT07408440Not yet recruiting
Testosterone gel for low sexual desire in women around or after menopause

This trial tests a testosterone gel (applied to the skin) to see if it helps women with low sexual desire or arousal around and after menopause. It may help by increasing your sexual interest and improving your response to sexual activity.

Houston, Texas
NCT07500766Not yet recruiting· Phase 2
Testosterone implants for low testosterone symptoms

This study tests a small implant placed under the skin that slowly releases testosterone to treat symptoms of low testosterone, like low energy or mood changes. It may help if you have low testosterone and do not plan to have children in the future.

NCT06733350Recruiting· Phase 4
Testosterone therapy for low testosterone in men with low-risk prostate cancer

This study tests whether testosterone replacement therapy can safely improve low testosterone levels in men with low-risk prostate cancer who are not getting immediate treatment. It aims to help men feel better without worsening their cancer.

Buffalo, New York

Hear when a new Hypogonadotropism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.